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ABSTRACT 
  The runt-related transcription factor Runx1 contributes to cell type specification and 
axonal targeting projections of the nociceptive dorsal root ganglion neurons. Runx1 is 
also expressed in the central nervous system, but little is known of its functions in brain 
development. At mouse embryonic day (E) 17.5, Runx1-positive neurons were detected 
in the ventrocaudal subdivision of the hypoglossal nucleus. Runx1-positive neurons 
lacked calcitonin gene-related peptide (CGRP) expression, whereas Runx1-negative 
neurons expressed CGRP. Expression of CGRP was not changed in Runx1-deficient 
mice at E17.5, suggesting that Runx1 alone does not suppress CGRP expression. 
Hypoglossal axon projections to the intrinsic vertical (V) and transverse (T) tongue 
muscles were sparser in Runx1-deficient mice at E17.5 compared to age-matched 
wild-type littermates. Concomitantly, vesicular acetylcholine transporter-positive axon 
terminals and acetylcholine receptor clusters were less dense in the V and T tongue 
muscles of Runx1-deficient mice. These abnormalities in axonal projection were not 
caused by a reduction in the total number hypoglossal neurons, failed synaptogenesis, or 
tongue muscles deficits. Our results implicate Runx1 in the targeting of ventrocaudal 
hypoglossal axons to specific tongue muscles. However, Runx1 deficiency did not alter 
neuronal survival or the expression of multiple motoneuron markers as in other 
neuronal populations. Thus, Runx1 appears to have distinct developmental functions in 
different brain regions. 
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INTRODUCTION 
  Runt-related (Runx) genes encode the DNA-binding α-subunit of the runt domain 
transcription factor farmily, also referred to as the polyomavirus enhancer-binding 
protein 2 (PEBP2)/core-binding factor (CBF) group. In Drosophila, the runt gene 
regulates multiple developmental processes, including segmentation and neuronal 
differentiation (Duffy et al., 1991; Dormand and Brand, 1998). In mammals, three Runx 
family transcription factors are crucial for the development of both neural and 
non-neural cells (for reviews, Ito, 2008; Stifani and Ma, 2009; Zagami et al., 2009). 
  Runx1 regulates the differentiation of hematopoietic cells in fetal liver, and its 
mutation is closely associated with human acute myeloid leukemia (De Brujin and 
Speck, 2004; Ito, 2004; Ichikawa et al., 2013). Runx1 is also expressed in the central 
and peripheral nervous systems (CNS and PNS). In the dorsal root ganglion (DRG), 
Runx1 is expressed initially in TrkA-positive small DRG neurons at early 
developmental stages (Levanon et al., 2001; Marmigère et al., 2006) and is involved in 
the cell type specification of non-peptidergic and peptidergic nociceptive neurons by 
repressing the expression levels of TrkA and calcitonin gene-related peptide (CGRP) 
and by promoting c-ret expression (Chen et al., 2006, Yoshikawa et al., 2007). Runx1 
also regulates the expression of various ionic channels and receptors involved in sensing 
pain, itch, and/or temperature (Chen et al., 2006; Yoshikawa et al., 2007; Abdel Samad 
et al., 2010; Liu and Ma, 2011; Lopes et al., 2012; Yang et al., 2013). Recent studies 
reported that Runx1 is expressed in putative mechanoreceptors (Lou et al., 2013; 
Yoshikawa et al., 2013) and is required for the development of unmyelinated 
low-threshold mechanoreceptors (Lou et al., 2013). In addition to cell type specification, 
Runx1 is involved in the regulation DRG axon projections toward central and peripheral 
targets (Chen et al., 2006; Yoshikawa et al., 2007; Yang et al., 2013).  
  In the developing CNS, Runx1 is expressed by neuron subpopulations in the 
branchiovisceral motor nuclei of the hindbrain and spinal motor nuclei of the cervical 
cord (Theriault et al., 2004; Dansen et al., 2005; Stifani et al., 2008; Lamballe et al., 
2011). Loss of Runx1 activity in the branchiovisceral nuclei induces cell death, 
suggesting that Runx1 is involved in the survival or proper maturation of 
branchiovisceral motoneurons (Theriault et al., 2004). In the spinal cord, both 
loss-of-function and gain-of-function studies suggest that Runx1 suppresses 
interneuron-specific developmental programs and maintains motoneuron characteristics 
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(Stifani et al., 2008). However, functional analysis of Runx1 in CNS development has 
been limited, and no studies have examined Runx1 function in axon targeting, in part 
because Runx1 deficiency results in lethality around embryonic day (E) 11.5 due to 
impaired fetal liver hematopoiesis (Okuda et al, 1996; Wang et al., 1996; Theriault et al., 
2004, 2005). To overcome this limitation, we utilized transgenic Runx1−/− mice in which 
liver hematopoietic cells are selectively rescued by the expression of Runx1 under the 
control of the GATA-1 promoter (Yokomizo et al., 2007). Selective rescue of Runx1 in 
hematopoietic cells enables these mice to survive until late embryonic stages.  
  Motoneurons of the hypoglossal nucleus (nXII) innervate tongue muscles. The 
topographic innervation of the tongue muscles by various nXII subpopulations has been 
revealed retrograde tracing (Aldes, 1995; Dobbins and Feldman, 1995; McClung and 
Goldberg, 1999, 2002). The nXII is divided into two major divisions, dorsal and ventral. 
Dorsal neurons project axons that form the lateral branch of the hypoglossal nerve (CN 
XII), whereas ventral neuron axons form the medial branch (Supporting Information Fig. 
S1; Dobbins and Feldman, 1995; Fregosi, 2011; Skouras et al., 2011). The lateral 
branch projects to the retractor muscles [extrinsic hypoglossus and styloglossus muscles, 
and intrinsic inferior and superior longitudinal (SL) muscles], whereas medial branch 
projects to the protruder muscles [extrinsic genioglossus (GG) muscle, and intrinsic 
vertical (V) and transverse (T) muscles] (Supporting Information Fig. S1; Fregosi, 
2011). Within these circuits there is more precise myotopy; for example, most neurons 
of the ventrocaudal subdivision of rat nXII project to the intrinsic V and T muscles in 
the anterior tongue (Supporting Information Fig. S1; Aldes, 1995). However, the 
mechanisms that specify this precise neuron−muscle connectivity remain unclear 
(Fregosi, 2011). 
  In the present study, we examined the embryonic expression patterns of Runx1 in 
hypoglossal neurons and the roles of Runx1 in axon guidance and neuromuscular 
junction (NMJ) formation in the tongue of wild-type and Runx1-deficient mice. 
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MATERIALS AND METHODS 
Animals 
We examined the wild-type expression pattern of Runx1 in mouse embryos (C57BL/6J, 
Japan SLC, Inc., Japan). Runx1 function was examined in transgenic Runx1-deficient 
mice (Runx1−/−::Tg) in which GATA-1-expressing hematopoietic cells are rescued by the 
G1-HRD-regulated expression of Runx1, whereas Runx1 expression remains deleted in 
most other cells, such as sensory and motor neurons (Yokomizo et al., 2007; Yoshikawa 
et al., 2007). These mice survive until late embryonic stages: and thus, we were able to 
analyze the roles of Runx1 in the development and targeting of hypoglossal axons. The 
Runx1+/+::Tg littermates were used as controls. All experiments were approved by the 
Animal Care Committee of the University of Tsukuba or Nihon University School of 
Medicine. 
 
Immunohistochemistry of the hypoglossal nucleus and tongues 
Mouse embryos were perfused transcardially with 4% paraformaldehyde (PFA) in 0.1 
M phosphate buffer (PB, pH 7.4) and immersed overnight (O/N) in the same fixative at 
4°C. The heads were removed, immersed successively in 10%, 20%, and 30% sucrose 
in 0.1 M PB and frozen in Tissue Tek OCT compound (Sakura Finetek Japan). Frontal 
and sagittal sections were cut at 12−16-µm thickness using a cryostat (HM 500 OM, 
MICROM International GmbH) and collected on MAS-coated glass slides (Matsunami 
Glass). If needed, sections were subjected to epitope retrieval by heating to 105°C for 5 
min in REAL Target Retrieval Solution (Dako). After treatment for 30 min at room 
temperature (RT) with 0.3% H2O2 in methanol, the sections were incubated for 1 h at RT 
in a blocking solution containing 5% normal serum and 0.1%−0.3% TritonX-100 in 
phosphate-buffered saline. The following primary antibodies were used in 
single-staining studies with peroxidase visualization: rabbit anti-Runx1 (Sigma-Aldrich; 
1:1000 dilution), mouse anti-Runx1 (a gift from Dr. Y. Ito; 1:1000), rabbit anti-CGRP 
(Chemicon; 1:4000), rabbit anti-choline acetyltransferase (ChAT) (Millipore; 1:600), 
and mouse anti-myosin (MF 20; Developmental Studies Hybridoma Bank; 1:400). The 
sections were incubated O/N to 2 O/N at 4°C with one of the primary antibodies in the 
blocking solution, and then with a biotinylated secondary antibody (Vector 
Laboratories; 1:500) for 1 h at RT. Immunolabeled sections were then incubated with 
the peroxidase-conjugated avidin-biotin complex (Vector Laboratories, 1:100) for 30 
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min at RT and the positive reactions visualized with 3,3’-diaminobenzidine (DAB) 
using the ImmunoPure Metal-Enhanced DAB Substrate Kit (Pierce). The sections were 
observed using a light microscope (AxioPlan 2, Carl Zeiss). For double-immunostaining, 
the sections were incubated O/N to 2 O/N at 4°C with (1) mouse anti-Runx1 (a gift 
from Dr. Y. Ito; 1:500) plus either rabbit anti-ChAT (Millipore; 1:600) or rabbit 
anti-CGRP (Chemicon; 1:2000), (2) rabbit anti-Runx1 (Sigma-Aldrich; 1:500) plus goat 
anti-c-Met (R&D systems; 1:200), or (3) mouse anti-Islet-1/2 (39.4D5; Developmental 
Studies Hybridoma Bank; 1:200) plus either rabbit anti-CGRP (1:2000), goat anti-c-Met 
(1:200), rabbit anti-c-ret (Immuno-Biological Laboratories; 1:50), or goat anti-Frizzled3 
(R&D Systems; 1:50). The sections were then incubated with Alexa Fluor 488-labeled 
and 594-labeled secondary antibodies (Invitrogen, 1:500) for 1 h at RT. Immunostained 
sections were observed at ×20 with a confocal laser scanning microscope 
(LSM510META ver3.2, Carl Zeiss) or a fluorescence microscope (BIOREVO BZ-9000, 
Keyence). Both Runx1−/−::Tg and Runx1+/+::Tg littermates were processed 
simultaneously. 
 
Cell counting 
For the analysis of Islet-1/2-positive/CGRP-negative cell number, serial frontal sections 
were cut throughout the nXII and every fifth section (12 µm) was stained with rabbit 
anti-CGRP (Chemicon; 1:2000) and mouse anti-Islet-1/2 (39.4D5; Developmental 
Studies Hybridoma Bank; 1:200) O/N at 4°C. Alexa Fluor 488-labeled and 594-labeled 
secondary antibodies were used for detection. Islet-1/2-positive/CGRP-negative cell 
number in each section was counted and the total number of these neurons was 
calculated. 
 
Tracing axonal projections 
Sagittal sections (12 µm) or frontal sections (16 µm) were incubated with rabbit 
anti-neurofilament 200 (NF-H, Sigma-Aldrich; 1:500) O/N at 4°C. An Alexa Fluor 
488-labeled secondary antibody was used for detection. Acetylcholine receptor (AChR) 
clusters (axonal projection sites) localized at postsynaptic sites were identified using 
Alexa Fluor 594-labeled α-bungarotoxin (α-BTX, Invitrogen; 1:500). 
 
Measurement of axon terminal area 
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Serial sagittal sections (12 µm) were cut using a cryostat and every fifth section was 
stained with primary antibodies against vesicular acetylcholine transporter (VAChT, 
Chemicon; 1:500) and CGRP (Chemicon, 1:2000) O/N at 4°C. Alexa Fluor 488-labeled 
and 594-labeled secondary antibodies were used for detection. Photomicrographs of 
three sections per mouse were acquired and analyzed. We divided sagittal images 
spanning from the tip to the base of the tongue into three areas: anterior body, posterior 
body, and base of the tongue (Supporting Information Fig. S2). For each section, six 200 
× 200 µm or 200 × 600 µm regions were analyzed. In addition, a 100 × 100 µm 
unstained region was analyzed for subtraction of background. 
 
Quantification of functional NMJ number 
For analysis of presynaptic NMJ bouton density (Maeda et al., 2004; Vinsant et al., 
2013), every second frontal section (16 µm) was stained with anti-VAChT and an Alexa 
Fluor 488 secondary antibody. AChR clusters localized in postsynaptic sites were 
identified with Alexa Fluor 594-labeled α-BTX (Invitrogen; 1:500). Any NMJ that had 
no sign of VAChT immunoreactivity was counted as denervated. For each area, 10−20 
sections were counted and results are presented as % area of anti-VAChT staining per 
section and number of AChR clusters per section. 
 
Retrograde labeling of motoneurons 
A pregnant mouse at 17 days postcoitum was anesthetized using isoflurane and the 
uterus was pulled out of the abdominal cavity. An incision was made to expose the 
mouths of the embryos. Alexa Fluor 594-labeled cholera toxin B subunit (CTB, 
Invitrogen) was injected locally (1 µg/µl in saline; 0.5 µl volume) into the GG muscle 
of the embryonic tongue using an ultra-thin stainless-steel needle (2-SV100A5-5, Altair 
Corporation; 100 µm OD) connected to a microinjector (IM-300, Narishige). Following 
injection, surgical incisions in the uterine wall were closed. The uterus was then 
repositioned in the abdominal cavity, and the abdominal wall and skin were closed to 
allow the embryos to continue normal development. Embryos were removed and 
perfused transcardially with 4% PFA 3−24 h after injection. Serial cryostat sections (12 
µm) were cut, and then incubated with rabbit anti-CGRP (Chemicon; 1:2000) O/N at 
4°C followed by incubation with Alexa Fluor 488-labeled secondary antibody 
(Invitrogen; 1:500) for 1 h at RT. All CGRP-negative GG motoneurons (presumptive 
 8 
Runx1-positive) in the hypoglossal nucleus were analyzed. 
 
Quantification of fluorescence intensity 
For quantification of the Fzd3 immunoreactivity in hypoglossal neurons, the signal 
intensity of Fzd3-positive motoneurons which expressed Islet-1/2 was measured using 
ImageJ (NIH). The signal intensity was expressed as average fluorescence intensity per 
cell. At least 280 neurons from each genotype were measured. 
 
Measurement of tongue volume 
Using every fifth frontal section (12 µm) containing whole tongues at E17.5, the areas 
of tongues in each section were measured and the tongue volume was calculated. 
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RESULTS 
Co-localization of Runx1 with ChAT but not CGRP in the hypoglossal nucleus 
  In wild-type (WT) E17.5 mouse embryos, the strong Runx1 expression was detected 
in the ventrocaudal subdivision of nXII (ventrocaudal nXII) (Fig. 1A,B). To determine 
the functions of these neurons, sections of nXII were doubled stained for Runx1 and 
ChAT, which is expressed by hypoglossal motoneurons (Takami et al., 1985; Trifonov et 
al., 2009). Virtually, all cells in nXII expressed ChAT (Fig. 1C), including 
Runx1-positive cells (Fig. 1D,E), suggesting that Runx1-positive cells are cholinergic 
motoneurons. However, many ChAT-positive neurons did not express Runx1 (Fig. 1E). 
Therefore, there are two neuronal subpopulations in nXII, 
ChAT-positive/Runx1-positive, and ChAT-positive/Runx1-negative. 
  We also examined the co-localization of Runx1 with two other hypoglossal 
motoneuron markers, CGRP or c-Met (Takami et al., 1985; Terrado et al., 1999; Caton 
et al., 2000; Wu and Levitt, 2013). In contrast to ChAT expression, few Runx1-positive 
cells expressed CGRP or c-Met in nXII at E17.5 (Fig. 1F-K). Runx1-positive neurons 
were restricted to the ventral division of the caudal nXII, whereas CGRP-positive and 
c-Met-positive neurons were localized to the dorsal division. This reciprocal expression 
of Runx1 and CGRP was detected as early as E13.5 (Fig. 1L-N). 
 
Conserved expression of motoneuron markers in Runx1−/−::Tg hypoglossal nucleus 
  In Runx1-deficient mice engineered to express β-gal in all neurons normally 
expressing Runx1, the number of spinal motor neurons co-expresing β-gal and ChAT 
was reduced (Stifani et al., 2008), suggesting that Runx1 expression may be involved in 
the positive regulation of ChAT. However, in the E17.5 ventrocaudal nXII, similar 
numbers of ChAT-positive cells were observed in Runx1+/+::Tg and Runx1−/−::Tg mice 
(26.30 ± 0.84/section vs. 24.85 ± 1.13/section, mean of 20 sections from four embryos 
for each genotype; Fig. 2A,B). We also examined the expression of two markers of 
cranial motoneurons, Islet-1/2 (Varela-Echavarría et al., 1996; Caton et al., 2000) and 
c-ret (Yu et al., 1998; Mikaels et al., 2000; Tamura et al., 2003). The total number of 
Islet-1/2-positive/CGRP-negative cells was similar in Runx1−/−::Tg and Runx1+/+::Tg 
mice (588.75 ± 8.75 vs. 567.50 ± 12.5; p = 0.21, Fig. 2E,G,H,J). Runx1 regulates c-ret 
expression in DRG neurons (Chen et al., 2006; Yoshikawa et al., 2007). However, c-ret 
expression in nXII did not differ between Runx1+/+::Tg and Runx1−/−::Tg mice (Fig. 
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2K,L). Thus, three features of the motor neuron phenotype (ChAT, Islet-1/2, and c-ret 
expressions) are maintained in the nXII even in the absence of Runx1, strongly 
suggesting that Runx1 is not necessary for maintenance of motor neuron phenotype. 
This Runx1-independence of hypoglossal motoneuron phenotype differs from 
embryonic spinal motoneurons, which follow the interneuron lineage in the absence of 
Runx1 (Stifani et al., 2008). Furthermore, unlike DRG neurons, CGRP expression is 
maintained in the absence of Runx1. As shown above, CGRP was not expressed in 
Runx1-positive cells in the ventrocaudal nXII of WT mice (Fig. 1F-H). The reciprocal 
expression of Runx1 and CGRP suggests CGRP downregulation by Runx1, as in the 
case of DRG neurons (Chen et al., 2006; Yoshikawa et al., 2007). However, CGRP 
expression was not detected in the ventrocaudal nXII of Runx1−/−::Tg mice (Fig. 
2C,D,F,I), indicating that Runx1 alone can not suppress CGRP expression in nXII. A 
recent study reported that c-Met is required for CGRP expression in DRG together with 
Runx1 repression (Gascon et al., 2010). Expression of c-Met in nXII (Caton et al., 2000; 
Wu and Levitt, 2013) was similar in the nXII of Runx1+/+::Tg and Runx1−/−::Tg mice 
(Fig. 2M,N).  
 
Altered hypoglossal axonal projections in Runx1−/−::Tg tongue muscles 
  Runx1 is expressed in neurons of the ventrocaudal nXII (Fig. 1A,B), neurons that 
innervate the intrinsic V and T muscles and extrinsic GG muscle through the medial 
branch of CN XII (Supporting Information Fig. S1; Aldes, 1995), suggesting that Runx1 
may be involved in axonal pathfinding to these muscles. Thus, we examined axonal 
projections to the intrinsic V and T muscles in Runx1−/−::Tg and Runx1+/+::Tg mice. We 
prepared both sagittal and frontal sections of the tongue at E17.5 and stained them with 
NF-H antibody. In Runx1+/+::Tg mice, hypoglossal axons ran longitudinally in the 
superficial region of the tongue and projected collaterals to the core region, forming a 
comb-like structure (Fig. 3A; Mbiene and Mistretta, 1997). In contrast to these normal 
longitudinal axon bundles, hypoglossal axons were sparse in the core region of the 
tongue of Runx1−/−::Tg mice (Fig. 3D). In addition, some hypoglossal axons were 
truncated and less tightly bundled in the V and T tongue muscles of Runx1−/−::Tg mice 
(Fig. 3J,O,P; Sokoloff and Burkholder, 2013). These results suggest that Runx1 in 
ventrocaudal hypoglossal neurons mediates axonal pathfinding to the V and T tongue 
muscles. 
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Reduced number of hypoglossal axon terminals in the V and T tongue muscles of 
Runx1−/−::Tg mice 
  Aldes (1995) reported that motoneurons in the ventrocaudal nXII project to the 
intrinsic V and T muscles in the anterior part of the tongue (Supporting Information Fig. 
S1). To examine if ventrocaudal projections to the V and T muscles from (normally) 
Runx1-positive neurons are altered by the absence of Runx1, we compared the total 
axon terminal areas in the V and T muscles of Runx1−/−::Tg and Runx1+/+::Tg mice. We 
divided the tongue into three anteroposterior regions, the anterior body, posterior body, 
and the base, and identified axon terminals in the V and T muscles by VAChT 
expression (Supporting Information Fig. S2 for detailed procedure). Expression of 
CGRP and Runx1 were mutually exclusive and CGRP expression was not changed in 
the nXII of Runx1−/−::Tg mice (Fig. 1); CGRP-positive and CGRP-negative axon 
terminals were assumed to arise from Runx1-negative and Runx1-positive neurons, 
respectively. 
  Sagittal sections were double-labeled with antibodies for VAChT, a general marker 
for motor axon terminals (Kobayashi et al., 2011), and CGRP, which has also been 
localized to motor axon terminals (Sato et al., 2011). Then, we analyzed three types of 
axon terminals, VAChT-positive, CGRP-positive, and VAChT-positive/CGRP-negative, 
representing all hypoglossal neurons, presumptive Runx1-negative hypoglossal neurons, 
and presumptive Runx1-positive hypoglossal neurons, respectively. In Runx1+/+::Tg 
mice, the area of VAChT-positive axon terminals was similar among the three tongue 
regions (Fig. 4A,G), indicating a relatively equal distribution. The area of 
CGRP-positive axon terminals (from Runx1-negative neurons) was smaller in the 
anterior body than in other regions (Fig. 4B,H), whereas the area of 
VAChT-positive/CGRP-negative axon terminals (from Runx1-positive neurons) was 
larger in the anterior body (Fig. 4C,I), consistent with the reported topographic 
innervation patterns of hypoglossal neurons (Fig. 4H-J; Aldes, 1995). In Runx1−/−::Tg 
mice, the area of VAChT-positive axon terminals was reduced to 64% of control 
(Runx1+/+::Tg mice) in the anterior body, to 50% in the posterior body, and to 46% in 
the base (p < 0.05) (Fig. 4A,D,G), indicating an overall reduction in innervation density. 
The area of CGRP-positive (presumptive normally Runx1-negative) axon terminals was 
were not altered relative to Runx1+/+::Tg mice (Fig. 4B,E,H), but the area of 
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VAChT-positive/CGRP-negative axon terminals (arising from neurons normally 
expressing Runx1) was significantly reduced in all three regions (to 30%, 36%, and 
32% of Runx1+/+::Tg mice, respectively; p < 0.05) (Fig. 4C,F,I). Thus, Runx1 
deficiency decreased innervation from the nXII to the V and T tongue muscles, 
consistent with a role in axon pathfinding to target muscles. 
 
Reduced NMJ numbers in the V and T tongue muscles in Runx1−/−::Tg mice 
  We then assessed whether Runx1 deficiency influenced the formation of NMJs in the 
V and T tongue muscles by analyzing VAChT-positive axon terminals and 
α-BTX-positive (α-BTX+) AChR clusters localized at the postsynaptic sites (Sokoloff 
and Burkholder, 2013). The distribution of AChR clusters appeared normal in 
Runx1−/−::Tg mice (Figs 5B,E, 9C,D,F,G). However, the number of α-BTX+ AChR 
clusters was significantly reduced in the anterior body, posterior body, and base of 
Runx1−/−::Tg V and T tongue muscles compared to Runx1+/+::Tg mice (Fig. 5G). 
Specifically, the number of α-BTX+ AChR clusters was reduced in the anterior body, 
posterior body, and base of the V muscle (Fig. 5H) and in the anterior and posterior 
body of the T muscle (Fig. 5I). However, most NMJs were still innervated in 
Runx1−/−::Tg mice and % innervation was not significantly different from Runx1+/+::Tg 
(Fig. 5J), suggesting that Runx1 is not involved in NMJ formation once the target 
muscle is reached.  
  We also examined whether aberrant axonal projection leads to failure to form proper 
NMJs, or to maintain them by analyzing E13.5 and E15.5 embryos. At E13.5, entry of 
hypoglossal axons into the body of the tongue was observed (Supporting Information 
Fig. S3A) but NMJs were immature (data not shown; Yamane et al., 2001). At E13.5, 
the hypoglossal axons were sparse in Runx1−/−::Tg tongue (Supporting Information Fig. 
S3B). Thereafter at E15.5, NMJs without innervation were observed in Runx1−/−::Tg 
tongue (Supporting Information Fig. S3C-H). Thus, reduction of axon terminals and 
AChR clusters in the V and T muscles in Runx1−/−::Tg mice at E17.5 seem to be due to 
the deficiency of axonal growth into the muscles. 
 
Increased axon terminal area in Runx1−/−::Tg GG tongue muscle 
  We examined whether axonal projections to the extrinsic GG muscle and intrinsic SL 
muscle, innervated by the medial and lateral branches of CN XII, respectively, are 
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altered by Runx1 deficiency. In contrast to V and T muscles (Fig. 4), the area of 
VAChT-positive axon terminals was higher in the extrinsic GG muscle of Runx1−/−::Tg 
mice relative to Runx1+/+::Tg mice (120%; p < 0.05) (Fig. 6A,D,G), whereas no changes 
were observed in the SL muscle (Fig. 6H), suggesting that Runx1 deficiency alters axon 
terminals primarily in muscles supplied by the medial branch. Similar to results in V 
and T muscles, most AChR clusters in the GG muscle were innervated in both 
Runx1+/+::Tg and Runx1−/−::Tg mice (Fig. 6I). The number of AChR clusters was not 
changed in Runx1−/−::Tg GG muscle (Fig. 6J), and the distribution of AChR clusters 
appeared normal in Runx1−/−::Tg mice (Fig. 6B,E). The number of AChR clusters was 
also similar in IL, HY, and STY muscles in Runx1+/+::Tg and Runx1−/−::Tg mice (IL, 
8.63 ± 1.16/section vs. 7.78 ± 0.78/section; HY, 5.85 ± 1.31/section vs. 4.45 ± 
0.99/section; STY, 7.78 ± 0.64/section vs. 6.58 ± 1.09/section). 
 
Hypoglossal axonal projections to the extrinsic GG muscles in Runx1−/−::Tg mice 
  Reduced VAChT area in the intrinsic V and T muscles (Fig. 4) and concomitant 
greater area in the extrinsic GG muscle in Runx1−/−::Tg mice (Fig. 6) suggest that some 
hypoglossal neurons switch targets in the absence of Runx1. To address this possibility, 
we examined hypoglossal neurons using retrograde labeling. CTB was injected into the 
GG muscle of E17.5 embryos, and the localization of CTB-labeled motoneurons was 
examined 3−4 h later. To focus on Runx1-expessing neurons, the tissues were stained 
with CGRP and all CGRP-negative neurons were identified as Runx1-positive neurons. 
In Runx1+/+::Tg mice, CTB-labeled hypoglossal neurons coexpressed CGRP and were 
localized to the lateral region of the ventrocaudal nXII, suggesting that the GG muscle 
is innervated by Runx1-negative motoneurons (Figs 7A-C, Supporting Information 
S1A,C). Axon terminal area was increased in Runx1−/−::Tg GG muscle; thus, some 
hypoglossal neurons may project ectopic axons to the GG muscle in the absence of 
Runx1. However, CTB-labeling was still restricted to CGRP-positive hypoglossal 
neurons in Runx1−/−::Tg mice (Fig. 7D-F), suggesting that the ventrocaudal hypoglossal 
neurons which are supposed to express Runx1 do not project to the GG muscle in 
substantial numbers in the absence of Runx1. 
 
The expression of Fzd3 in Runx1−/−::Tg hypoglossal nucleus  
  A recent study reported that the Wnt receptor Frizzled3 (Fzd3) also contributes to 
 14 
axonal pathfinding of hypoglossal neurons (Hua et al., 2013; Hua et al., 2014) as tongue 
muscle innervation was reduced in Fzd3-deficient mice. Considering the similar 
phenotypes of Fzd3-deficient and Runx1-deficient mice, it is possible that Fzd3 may 
mediate the effects of Runx1. Fzd3 expression was reduced in the nXII of Runx1−/−::Tg 
mice (877.1 ± 48.4, p < 0.005) (Fig. 8D,F,G) compared to Runx1+/+::Tg mice (1956.5 ± 
199.0) (Fig. 8A,C,G), suggesting that Runx1 promotes Fzd3 expression. Further studies 
are necessary to determine whether Runx1 mediates axonal pathfinding of hypoglossal 
neurons through Fzd3. 
 
Runx1 deficiency has no effects on tongue muscles  
  An alternative explanation for these results is that altered axonal projections to the 
tongue are caused by abnormalities in the tongue muscle as muscles provide cues for 
both axon guidance and synaptogenesis. To examine this possibility, we first examined 
the expression of Runx1 in WT tongue at E17.5. Runx1 was detected in connective 
tissue papilla but not in tongue muscles (Fig. 9A). In sections stained with hematoxylin 
and eosin, the overall size of the tongue (Runx1+/+::Tg mice, 5.92 ± 0.30 mm3 vs. 
Runx1−/−::Tg mice, 6.07 ± 0.19 mm3) and the morphology of the tongue muscles were 
not noticeably altered in Runx1−/−::Tg mice, although there were minor differences in 
the interstitial tissue space around the tongue tip. There was also no significant 
difference in myosin expression in Runx1−/−::Tg tongue muscles (Fig. 9B,E). In addition, 
the number of myofibrils in V and T muscles was similar in Runx1+/+::Tg and 
Runx1−/−::Tg mice (for V muscle, 31.2 ± 1.76/section vs. 29.7 ± 2.75/section; for T 
muscle, 32.2 ± 1.02/section vs. 31.0 ± 1.55/section). These results suggest that the 
abnormalities in axonal projections are mainly attributable to deficient of Runx1 in 
hypoglossal neurons rather than Runx1-dependent changes in muscle signaling and 
function. 
 
 
DISSCUTION 
  In the present study, we mapped Runx1 expression in hypoglossal neurons of mouse 
embryos and examined the roles of Runx1 in cell type specification and axonal 
pathfinding to tongue muscles. In nXII, Runx1-positive neurons were located in the 
ventrocaudal subdivision. These Runx1-positive neurons did not express CGRP, and 
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CGRP-positive neurons did not express Runx1. Expression of CGRP was not changed 
in Runx1-deficient mice, indicating that Runx1-mediated CGRP downregulation is not 
responsible for this mutually exclusive expression pattern. Runx1 deficiency altered 
axonal projections to selected tongue muscles and concomitantly reduced the density of 
axon terminals and postsynaptic AChR clusters. In contrast, Runx1 deficiency did not 
alter the number of hypoglossal neurons or the proportion of synapses containing both 
presynaptic and postsynaptic elements (VAChT and AChR clusters, respectively). Taken 
together, these results suggest that Runx1 is involved in targeting ventrocaudal 
hypoglossal neurons to specific muscles but is not necessary for neuronal survival, 
motoneuron specification, or synaptic development.  
	  
Expression of Runx1 in hypoglossal nucleus 
  Previous studies using Runx1 lacZ/+ mice in which β-gal gene was inserted into the 
Runx1 locus to produce a Runx1−β-gal fusion protein implicated Runx1 expression in 
the regional control of brain development (Levanon et al., 2001; Theriault et al., 2004). 
In contrast to DRG, spinal motoneurons, and other brainstem population, the pattern of 
Runx1 expression in hypoglossal neurons and the function of Runx1 in survival, 
differentiation, and axonal pathfinding in nXII had not been studied. 
  Immunohistochemical staining of WT mice revealed that Runx1 expression in nXII is 
limited to the ventrocaudal subdivision at E17.5, a subdivision previously shown to 
project to both the intrinsic V and T muscles and the extrinsic GG muscle in the tongue 
(Aldes, 1995). Runx1 deficiency markedly reduced axonal projections to the V and T 
tongue muscles, while producing a very modest increase in GG innervation strongly 
suggesting that pathfinding (but not survival or synaptogenesis) is dependent on Runx1 
expression.   
 
Regulation of ChAT, Islet-1/2, and CGRP expressions 
  In the spinal cord of mouse embryos, Runx1 is expressed in selected motoneuron 
subtypes in the cervical spinal cord (Dansen et al., 2005; Stifani et al., 2008; Lamballe 
et al., 2011). In the spinal cord of Runx1-deficient mice (E13.5 and 18.5), there were 
fewer neurons expressing motoneuron-specific markers such as ChAT and Islet-1/2, and 
more neurons expressing interneuron-specific markers such as Pax2 (Stifani et al., 
2008), implicating Runx1 in lineage specification of spinal motoneurons. Moreover, 
 16 
overexpression of Runx1 in the chick spinal cord decreased the expression of 
interneuron-specific markers and increasing expression of motoneuron-specific markers. 
These results suggest that Runx1 suppresses interneuron-specific developmental 
programs and maintains motoneuron characteristics in the spinal cord (Stifani et al., 
2008). Similar functions of Runx1 and Runx3 in neuronal subtype specification from 
bipotential or multipotential neuronal progenitors have been demonstrated during 
development of PNS sensory neurons (for reviews, Inoue et al., 2008; Lallemend and 
Ernfors, 2012). Conversely, in the nXII, a region predominantly populated by 
motoneurons with few interneurons (Takasu and Hashimoto, 1988; Sturrock, 1991), 
ChAT and Islet-1/2 expression levels were not altered by Runx1 deficiency. Thus, 
Runx1 does not contribute substantially to survival or maintenance of the motoneuron 
phenotype in the nXII. 
  CGRP is also expressed in the nXII (Takami et al., 1985; Terrado et al., 1999), and 
our immunohistochemical results showed that  the nXII contains two distinct and 
non-overlapping motoneuron populations, Runx1-negative/CGRP-positive and 
ventrocaudal  Runx1-positive/CGRP-negative. Previous studies reported that CGRP 
expression is upregulated in the DRG of Runx1-deficient mice, suggesting that Runx1 
suppresses CGRP expression (Chen et al., 2006; Kramer et al., 2006; Yoshikawa et al., 
2007). The reciprocal expression of Runx1 and CGRP in nXII also suggests that CGRP 
is suppressed by Runx1. However, CGRP expression was still lost in the ventrocaudal 
nXII of Runx1-decicient mice and maintained elsewhere in the nXII, indicating that 
Runx1 is not sufficient to suppress CGRP expression in the nXII. Alternatively, 
hepatocyte growth factor (HGF)–c-Met signaling both represses Runx1 expression and 
induces CGRP expression in DRG neurons (Gascon et al., 2010). In addition, Runx1 
and c-Met are reciprocally regulated in DRG neurons (Gascon et al., 2010). However, 
c-Met expression was still absent in the ventrocaudal nXII of Runx1-decicient mice. In 
contrast to DRG, Runx1 is positively regulated by c-Met in spinal motor neurons 
(Lamballe et al., 2011). The relationships among Runx1, c-Met, and CGRP in the 
hypoglossal neurons appear distinct from those described in spinal motoneurons or 
DRG neurons. 
   
Roles of Runx1 in myotopic axonal projection to the tongue 
  Axonal projection to specific targets during development is crucial for proper motor 
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function. Runx1 is expressed in selected sensory neurons where it regulates axonal 
projection to specific targets (Chen et al., 2006; Yoshikawa et al., 2007; Yang et al., 
2013). The present study demonstrates a similar function in the nXII, with Runx1 
expression necessary for axonal projection from the ventrocaudal nXII to intrinsic V 
and T muscles of the tongue. In contrast to the effects of Runx1 deficiency on 
projections to V and T muscles, there may have been a modest increase in presynaptic 
projections to the GG muscle, indicating that axons are not redirected to ectopic sites. 
Rather, immunohistochemical staining of serial sections revealed that Runx1-deficient 
axons were truncated and fasciculation was incomplete. Thus, Runx1 appears necessary 
for axonal organization in the CN XII as well as for axonal projection. 
  It is still unclear how axons of hypoglossal neurons are guided to spesific target 
muscles (Fregosi, 2011). Abnormal axonal projections of hypoglossal neurons were 
reported in mice deficient in HGF or its receptor (encoded by c-Met) (Caton et al., 
2000), RhoA and Rho-kinase (Rho-K) (Kobayashi et al., 2011), and neuropilin-1 (Huettl 
and Huber, 2011). Knockout of neuropilin-1 from somatic motoneurons impaired the 
initial fasciculation and the assembly of hypoglossal rootlets but not later axon guidance 
(Huettl and Huber, 2011). In Runx1-deficient mice, nXII expression of c-Met was 
normal and initial projection and bundle formation of CN XII appeared normal at 
E11.5–E13.5 (data not shown). Thus, it is unlikely that the altered axonal projection 
from nXII in Runx1-deficient mice is associated with c-Met, HGF, RhoA, Rho-K, or 
neuropilin-1 dysfunction. 
  In RetNkx6.2-Cre, RhoA, Rho-K, and N-catenin mutant mice, each with specifically 
deleted cranial motoneurons, axonal projections to the tongue muscles were reduced, 
together with a reduction in the number of hypoglossal neurons (Baudet et al., 2008; 
Kobayashi et al., 2011; Uemura and Takeichi, 2011). A reduction in axonal projection 
was also observed in Runx1-deficient mice, but there was no detectable reduction in the 
number of hypoglossal neurons. A recent study reported that Fzd3 controls axonal 
projection of hypoglossal neurons (Hua et al., 2013; Hua et al., 2014). The expression of 
Fzd3 was lower in the nXII of Runx1-deficient mice, suggesting a functional association 
of Runx1 with Fzd3 in axonal projection. In addition, Fzd3 deficiency also caused cell 
death of some cranial and spinal neurons (Hua et al., 2013), but reduced Fzd3 
expression was not associated with reduced neuronal survival in the nXII. Thus, Runx1 
appears specialized for axonal growth and or pathfinding in the nXII, possibly by 
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interacting with Fzd3, but unlike Ret, RhoA, Rho-K, or N-catenin, does not contribute 
to progenitor proliferation or neuronal survival. 
  Specific myotopic axon projections require the coordinated activity of multiple 
guidance and growth factors (Bonanomi and Pfaff, 2010; Demireva et al., 2011; 
Bonanomi et al., 2012; Hua et al., 2013; Hua et al., 2014). For example, both loss of 
Nkx6.1 expression and ectopic Nkx6.1 expression alter the position of selected motor 
pools in the spinal cord and redirect axons to new muscle targets (De Marco Garcia and 
Jessell, 2008). In Runx1-deficient mice, axon terminals were decreased in the V and T 
muscles and increased slightly in the GG muscle, but no ectopic hypoglossal neurons 
were detected projecting to the GG muscle, suggesting that Runx1 deficiency altered 
axonal projection but did not switch the selectivity from the proper target muscles. 
Runx1 may regulate downstream factors that control motor axonal projection. The 
interaction of membrane bound ephrins with ephrin receptors (Ephs) guides axonal 
pathfinding through both repulsive and attractive interactions (Egea and Klein 2007; 
Reber et al., 2007). Indeed, ephrin–Eph signaling controls the topographic projections 
of a variety of neurons (Kao et al., 2012; Dudanova and Klein, 2013). A recent report 
showed that c-ret mediates Ephrin-A reverse signaling in motoneurons (Bonanomi et al., 
2012). In addition, lack of c-ret in hypoglossal neurons resulted in a developmental 
deficit of axon terminal maturation (Baudet et al., 2008). We and others reported that 
Runx1 regulates c-ret expression in DRG neurons (Chen et al., 2006; Yoshikawa et al., 
2007). However, c-ret expression was not changed in the nXII of Runx1-deficient mice. 
Taken together, our data demonstrate that Runx1 is critical for regulating axonal 
projections of specific hypoglossal neurons, but this function is likely independent of 
c-ret. The downstream molecular signaling pathways activated by Runx1 remain to be 
identified. 
  Intramuscular nerve branching defects in skeletal muscles, including the latissimus 
dorsi (LD), cutaneous maximus, and diaphragm, were reported in Pea3-deficient, 
erbB2-deficient, and damage-induced neuronal endopeptidase (DINE)-deficient mice 
(Lin et al., 2000; Haase et al., 2002; Livet et al., 2002; Nagata et al., 2010). DINE is 
expressed in CNS neurons, including hypoglossal neurons, and the PNS neurons from 
early development (Nagata et al., 2006). DINE deficiency resulted in altered 
arborization of intramuscular nerves in the diaphragm and LD muscles, whereas 
motoneurons and initial axonal outgrowth were normal (Nagata et al., 2010). Schwann 
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cells also affect fasciculation and generation of motor axons (Lin et al., 2000). In 
Runx1-deficient mice, hypoglossal axons branched normally from the main 
intramuscular nerve, but some axons were less tightly bundled and truncated. Runx1 
also promoted axonal branching in neurogenin-2-fated boundary cap neural crest stem 
cells (Marmigère et al., 2006). Thus, loss of Runx1 may regulate axon–Schwann cell 
interactions in the tongue muscles to maintain appropriate pathfinding to target muscles 
or interact with other regulators of axonal branching, such as DINE. 
 
NMJ formation 
  Formation of NMJs requires the coordinated interaction of neuronal-, Schwann cell-, 
and muscle-derived factors. Indeed, dysfunction of specific synaptogenic molecules in 
motor axons, terminal Schwann cells, or skeletal muscles can cause failure of NMJ 
formation (Witzemann, 2006; Wu et al., 2010; Ferraro et al., 2012; Hubbard and 
Gnanasambandan, 2013). For example, agrin, a heparin-sulfate proteoglycan secreted 
by motoneurons, induces clustering of AChRs on the postsynaptic side of the junction 
(muscle membrane). During diaphragm development, AChR clusters that first form in 
the middle region of diaphragm muscle fibers are enlarged if innervated but disappear if 
not (Wu et al., 2010). In Runx1-deficient mice, both axon terminals (VAChT-positive 
areas) and AChR clusters were reduced in V and T tongue muscles. However, most 
NMJs that remained were normally innervated, suggesting that Runx1 is not directly 
involved in NMJ formation. 
 
Tongue muscles 
  The skeletal muscle proteins MuSK, LRP4, and rapsyn are critical for NMJ formation 
(Witzemann, 2006; Wu et al., 2010; Ferraro et al., 2012; Hubbard and Gnanasambandan, 
2013). In Runx1-deficient mice, the distribution of AChR clusters appeared normal. In 
addition, Runx1 was expressed in connective tissue papilla of tongue but not in 
innervated skeletal muscles at E17.5. Moreover, Runx1 does not directly regulate AChR 
δ-subunit gene expression in developing muscles (Zhu et al., 1994). These results 
suggest that Runx1 does not affect skeletal muscles directly during late embryonic 
stages and likely functions via a presynaptic mechanism.  
 
  In conclusion, we demonstrate novel functions of Runx1 in axonal projection of 
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hypoglossal motor neurons. Runx1 deficiency perturbs the proper projection of 
hypoglossal axons to tongue muscles during embryonic development. Further studies 
are needed to identify the downstream targets of the Runx1 transcription factor. 
However, in contrast to other PNS and spinal neuron populations, Runx1 does not 
contribute to neuronal survival, maintenance of motoneuron phenotype, or 
synaptogenesis of hypoglossal neurons. 
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FIGURE LEGENDS 
Figure 1. Expression of Runx1, ChAT, CGRP, and c-Met in the wild-type hypoglossal 
nucleus (WT nXII). (A) Runx1 was localized in the ventrocaudal nXII in the mouse 
embryo. Sagittal section of nXII at E17.5 stained by anti-Runx1 antibody and thionin. 
(B) A schematic representation showing the region of Runx1 expression (stippled area). 
(C-E) Immunostaining for ChAT (C, green) and Runx1 (D, red) in WT nXII at E17.5 
(frontal sections). E is the merged image of C and D. All Runx1+ neurons expressed 
ChAT (E). (F-H) Immunostaining for Runx1 (F, red) and CGRP (G, green) in WT nXII 
at E17.5 (frontal sections). H is the merged image of F and G. Runx1 and CGRP were 
expressed in separate neuron populations (H). (I-K) Immunostaining for Runx1 (I, red) 
and c-Met (J, green) in WT nXII at E17.5 (frontal sections). K is the merged image of I 
and J. (L-N) Immunostaining for Runx1 (L, red) and CGRP (M, green) in WT nXII at 
E13.5 (sagittal sections; rostral is right and caudal is left). Runx1 and CGRP were 
expressed separately in most neurons (N). Arrows indicate Runx1+ neurons. The nXIIs 
were outlined by the dotted lines. Scale bar: 100 µm (E,H,K,N) 
 
Figure 2. Runx1 deficiency does not alter the expression of ChAT, CGRP, Islet-1/2, 
c-ret, or c-Met in the mouse nXII at E17.5. (A,B) Immunostaining for ChAT in the nXII 
of Runx1+/+::Tg (A) and Runx1−/−::Tg mice (B). A similar ChAT expression distribution 
was observed in both genotypes. (C,D) Immunostaining for CGRP in the nXII of 
Runx1+/+::Tg (C) and Runx1−/−::Tg mice (D). A similar CGRP expression distribution 
was observed. (E-J) Immunostaining for Islet-1/2 (E,H, red) and CGRP (F,I, green) in 
the nXII of Runx1+/+::Tg (E-G) and Runx1−/−::Tg mice (H-J). G and J are merged 
images of E and F, and H and I, respectively. (K,L) Immunostaining for c-Met in the 
nXII of Runx1+/+::Tg (K) and Runx1−/−::Tg (L). (M,N) Immunostaining for c-ret in nXII 
of Runx1+/+::Tg (L) and Runx1−/−::Tg (N). Similar Islet-1/2, c-Met, and c-ret expression 
patterns were observed in both genotypes, suggesting that Runx1 does not control the 
expression of any of these motoneuron marker proteins. The nXIIs were outlined by the 
dotted lines. Scale bar: 100 µm (B,D,J,L,N) 
 
Figure 3. Runx1 deficiency disrupts axonal projection to tongue muscles and CN XII 
fasciculation. The expression of the axon marker neurofillament-200 (NF-H) and the 
motor endplate marker alpha-bungarotoxin (α-BTX) were examined in the tongue of 
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Runx1+/+::Tg and Runx1−/−::Tg mice at E17.5. (A-L) Sagittal (A-F) and frontal (G-L) 
sections of the tongue. Fewer NF-H+ axons were detected in tongues of Runx1−/−::Tg 
mice (D) compared to Runx1+/+::Tg mice (A). Axonal projection to the vertical (V, 
asterisks) and transverse (T, boxed areas, arrows) tongue muscles (A,D,G,J, green), and 
(α-BTX-binding) acetylcholine receptor (AChR) clusters (B,E,H,K, red), and merged 
images (C,F,I,L) in Runx1+/+::Tg (A-C,G-I) and Runx1−/−::Tg mice (D-F,J-L) at E17.5. 
Runx1−/−::Tg tongue exhibited many truncated axons (J). (M-P) Expanded images of 
NF-H+ axons (green) and α-BTX+ AChR clusters (red) in Runx1+/+::Tg (M,N) and 
Runx1−/−::Tg (O,P) V and T muscles at E17.5. Axons appeared less tightly bundled in 
Runx1−/−::Tg tongue. Scale bar: 100 µm (F,L,P) 
 
Figure 4. Runx1 deficiency reduces the total number of tongue muscle NMJs 
originating from ventrocaudal hypoglossal neurons but not CGRP+ neurons. The area of 
VAChT+/CGRP− axon terminals but not CGRP+ axon terminals was reduced in 
Runx1−/−::Tg tongue at E17.5. (A-F) Photomicrographs showing the expression of 
VAChT (A,D, green) and CGRP (B,E, red) in the anterior body of the tongue in 
Runx1+/+::Tg (A-C) and Runx1−/−::Tg mice (D-F). Sagittal sections. C and F are merged 
images of A and B, and D and E, respectively. (G) The area of VAChT+ axon terminals 
from all hypoglossal neurons was lower in the anterior body, posterior body, and base of 
the tongue in Runx1−/−::Tg mice. (H) The area of CGRP+ axon terminals from Runx1− 
neurons was unchanged in Runx1−/−::Tg compared to Runx1+/+::Tg mice. (I) The area of 
VAChT+/CGRP− axon terminals from Runx1+ neurons was significantly lower in the 
tongue anterior body, posterior body, and base in Runx1−/−::Tg mice. (J) Schematic 
representation of hypoglossal axon terminals in the tongue. n = 3 mice for each 
genotype, *p < 0.05, #p < 0.05 by Student’s t-test. * compared to Runx1+/+::Tg, # 
compared to the anterior body of the tongue. The bars represent means ± SEM. Scale 
bar: 100 µm 
 
Figure 5. Reduced numbers of NMJs but no change in the innervated fraction in V and 
T tongue muscles of Runx1−/−::Tg mice at E17.5. VAChT+ axon terminals (A,D, green) 
and α-BTX+ AChR clusters (B,E, red) and merged images (C,F) in Runx1+/+::Tg (A-C) 
and Runx1−/−::Tg (D-F) V and T tongue muscles. (G) The number of α-BTX+ AChR 
clusters was reduced in the anterior body, posterior body, and base of Runx1−/−::Tg V 
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and T tongue muscles compared to Runx1+/+::Tg. (H) The number of α-BTX+ AChR 
clusters was reduced in the anterior body, posterior body, and base of Runx1−/−::Tg V 
tongue muscle compared to Runx1+/+::Tg. (I) The number of α-BTX+ AChR clusters 
was reduced in the anterior body, and posterior body of Runx1−/−::Tg T tongue muscle 
compared to Runx1+/+::Tg. (J) Total NMJ innervation (% of all VAChT+ regions 
expressing α-BTX+ AChR clusters) was not changed in Runx1−/−::Tg V and T tongue 
muscles, as the number of α-BTX+ AChR clusters and VAChT+ axon terminals were 
decreased proportionally. n = 3 mice for each group, *p < 0.05, **p < 0.01 by Student’s 
t-test. The bars represent means ± SEM. Scale bar: 100 µm 
 
Figure 6. Increased VAChT+ axon terminal area in the genioglossus (GG) tongue 
muscle but not superior longitudinal (SL) tongue muscle in Runx1−/−::Tg mice at E17.5. 
VAChT+ axon terminals (A,D, green) and α-BTX+ AChR clusters (B,E, red) and merged 
images (C,F) in Runx1+/+::Tg (A-C) and Runx1−/−::Tg (D-F) GG tongue muscles at 
E17.5. (G) The area of VAChT+ axon terminals was significantly increased in 
Runx1−/−::Tg GG muscle. (H) The area of VAChT+ axon terminals was not changed in 
Runx1−/−::Tg SL tongue muscle. (I) The percentage of NMJ innervation was not 
changed in Runx1−/−::Tg GG tongue muscle. (J) The number of AChR clusters was not 
changed in Runx1−/−::Tg GG tongue muscle. n = 3 mice for each group, *p < 0.05 as 
determined by Student’s t-test. The bars represent means ± SEM. Scale bar: 25 µm 
 
Figure 7. Runx1 deficiency does not result in ectopic innervation of other tongue 
muscles. Similar distribution of hypoglossal neurons labeled retrogradely from GG 
tongue muscle tracer injection in Runx1+/+::Tg and Runx1−/−::Tg mice. (A-F) The 
distribution of retrogradely labeled hypoglossal neurons in the ventrocaudal nXII of 
Runx1+/+::Tg (A-C) and Runx1−/−::Tg mice (D-F) at E17.5. Cholera toxin B subunit 
(CTB) was injected into GG tongue muscle for retrograde labeling of hypoglossal 
neurons (A,D, red). CGRP+ hypoglossal neurons (B,E, green) and merged images of A 
and B (C) and D and E (F). Many CGRP+ CTB-labeled hypoglossal neurons were 
observed in both Runx1+/+::Tg (C) and Runx1−/−::Tg mice (F), indicating that a Runx1 
deficit did not substantially alter axonal projections to the GG muscle. The dorsal and 
ventral regions were outlined by the dotted lines. n = 4 mice for each group. Scale bar: 
50 µm 
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Figure 8. Reduced expression of Fzd3 in the nXII of Runx1−/−::Tg mice at E17.5. (A-F) 
Immunostaining for Fzd3 (A,D, green) and Islet-1/2 (B,E, red) and merged images 
(C,F) in Runx1+/+::Tg (A-C) and Runx1−/−::Tg mice (D-F). (G) Fzd3 expression was 
lower in hypoglossal neurons of Runx1−/−::Tg compared to Runx1+/+::Tg mice. The 
nXIIs were outlined by the dotted lines. n = 3 mice for each group, *p < 0.005 as 
determined by Student’s t-test. The bars represent means ± SEM. Scale bar: 100 µm 
 
Figure 9. Runx1 deficiency did not induce tongue muscle abnormalities. (A) The 
expression of Runx1 in the tongue of WT mice at E17.5. Runx1 was expressed in the 
dermal papillae (arrows) but not in tongue muscle tissue. (B-G) Immunostaining for 
myosin (B,E, green) and α-BTX (C,F, red), and merged images (D,G) of the tongue in 
Runx1+/+::Tg (B-D) and Runx1−/−::Tg mice (E-G) at E17.5. There were no demonstrable 
changes in myosin and α-BTX distribution or immunostaining intensity. Vs and Ts 
indicate the vertical and transverse tongue muscles, respectively. Scale bar: 100 µm 
(A,G) 
 
Supplemental Figure 1. Myotopy of the axonal projection from nXII to the tongue. (A) 
Schematic representation showing frontal sections of nXII from rostral to caudal. The 
left half shows the compartments of nXII and associated nerve branches. The nXII is 
divided into two major compartments, a dorsal division (Dd) and a ventral division (Vd), 
the axons of which from the lateral branch (Lbr) and medial branch (Mbr) of the 
hypoglossal nerve, respectively. The right half shows the locations of motoneurons that 
innervate the genioglossus (GG), hypoglossus (HY), inferior longitudinal (IL), superior 
longitudinal (SL), styloglossus (STY), transverse (T), and vertical (V) tongue muscles. 
(B) The distribution of axon terminals in the core region of the tongue. The body and 
the base of tongue are innervated by motoneurons in the caudal and rostral parts of the 
ventral nXII, respectively. These figures are reconstructed according to Aldes (1995). 
(C) The distribution of retrogradely labeled hypoglossal neurons in the ventrocaudal 
nXII at E17.5 in WT mice. CTB was injected into the extrinsic GG tongue muscle (red) 
and intrinsic V and T tongue muscles (green) to label projecting hypoglossal neurons. 
Scale bar: 50 µm 
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Supplemental Figure 2. Method for measurement of axon terminal area in the tongue 
muscles of Runx1+/+::Tg and Runx1−/−::Tg mice. We took six images from sagittal 
sections spanning from the tip to the base of the tongue. Boxes 1 and 2, 3 and 4, and 5 
and 6 correspond to the anterior body, the posterior body, and the base of the tongue, 
respectively. Total areas of VAChT+ axon terminals in box 1 (200 × 200 µm; a, a’) and 
in boxes 2−6 (200 × 600 µm; b, b’) were measured, revealing a reduced axon terminal 
density in the tongue muscles of Runx1−/−::Tg mice. 
 
Supplemental Figure 3. Effects of Runx1 deficiency on axonal projection to tongue 
muscles. (A,B) The expression of the axon marker neurofillament-200 (NF-H) was 
examined in the tongue of Runx1+/+::Tg and Runx1−/−::Tg mice at E13.5. Fewer NF-H+ 
axons were detected in tongues of Runx1−/−::Tg mice (B) compared to Runx1+/+::Tg 
mice (A) at E13.5. (C-H) The expression of the axon terminal marker VAChT and the 
motor endplate marker alpha-bungarotoxin (α-BTX) was examined in the tongue of 
Runx1+/+::Tg and Runx1−/−::Tg mice at E15.5. VAChT+ axon terminals (C,F, green) and 
(α-BTX-binding) acetylcholine receptor (AChR) clusters (D,G, red) and merged images 
(E,H) in Runx1+/+::Tg (C-E) and Runx1−/−::Tg (F-H) tongue muscles. Only α-BTX 
expression (denervated neuromuscular junction, boxed areas) were observed frequently 
in Runx1−/−::Tg tongue muscles. Scale bar: 100 µm (B,H) 
 












